Advisory Committee on the Medical Uses of Isotopes: Call for Nominations, 42905-42906 [2021-16706]
Download as PDF
<![CDATA[
Federal Register / Vol. 86, No. 148 / Thursday, August 5, 2021 / Notices
NATIONAL SCIENCE FOUNDATION
Membership of National Science
Foundation’s Senior Executive Service
Performance Review Board
AGENCY:
ACTION:
National Science Foundation.
Notice.
The National Science
Foundation is announcing the members
of the Senior Executive Service
Performance Review Board.
SUMMARY:
Comments should be
addressed to Branch Chief, Executive
Services, Division of Human Resource
Management, National Science
Foundation, Room W15219, 2415
Eisenhower Avenue, Alexandria, VA
22314.
ADDRESSES:
Ms.
Jennifer Munz at the above address or
(703) 292–2478.
FOR FURTHER INFORMATION CONTACT:
The
membership of the National Science
Foundation’s Senior Executive Service
Performance Review Board is as follows:
SUPPLEMENTARY INFORMATION:
khammond on DSKJM1Z7X2PROD with NOTICES
Karen Marrongelle, Chief Operating
Officer, Chairperson
Wonzie Gardner, Chief Human Capital
Officer and Office Head, Office of
Information and Resource
Management
Janis Coughlin-Piester, Deputy Office
Head, Office of Budget, Finance and
Award Management
Joanne Tornow, Assistant Director,
Directorate for Biological Sciences
Erwin Gianchandani, Senior Advisor,
Office of the Director
Michael Wetklow, Deputy Chief
Financial Officer and Division
Director, Budget Division
Linda Sapochak, Division Director,
Division of Materials Research,
Directorate for Mathematical &
Physical Sciences
William Malyszka, Division Director,
Division of Human Resource
Management and PRB Executive
Secretary
This announcement of the
membership of the National Science
Foundation’s Senior Executive Service
Performance Review Board is made in
compliance with 5 U.S.C. 4314(c)(4).
Dated: August 2, 2021.
Suzanne H. Plimpton,
Reports Clearance Officer, National Science
Foundation.
[FR Doc. 2021–16756 Filed 8–4–21; 8:45 am]
BILLING CODE 7555–01–P
VerDate Sep<11>2014
17:07 Aug 04, 2021
Jkt 253001
NUCLEAR REGULATORY
COMMISSION
Advisory Committee on the Medical
Uses of Isotopes: Call for Nominations
U.S. Nuclear Regulatory
Commission.
ACTION: Call for nominations.
AGENCY:
The U.S. Nuclear Regulatory
Commission (NRC) is soliciting
nominations for the position of
Radiation Safety Officer on the Advisory
Committee on the Medical Uses of
Isotopes (ACMUI). Nominees should
currently be functioning as a Radiation
Safety Officer.
DATES: Nominations are due on or
before October 4, 2021.
FOR FURTHER INFORMATION CONTACT: Ms.
Kellee Jamerson, U.S. Nuclear
Regulatory Commission, Office of
Nuclear Material Safety and Safeguards;
(301) 415–7408; Kellee.Jamerson@
nrc.gov.
SUMMARY:
SUPPLEMENTARY INFORMATION:
Nomination Process: Submit an
electronic copy of resume or curriculum
vitae, along with a cover letter, to Ms.
Kellee Jamerson, Kellee.Jamerson@
nrc.gov. The cover letter should describe
the nominee’s current involvement as a
Radiation Safety Officer and express the
nominee’s interest in the position.
Please ensure that the resume or
curriculum vitae includes the following
information, if applicable: Education;
certification(s); professional association
and committee membership activities;
duties and responsibilities in current
and previous clinical, research, and/or
academic position(s).
ACMUI members possess the medical
and technical skills needed to address
evolving issues. The current
membership is comprised of the
following professionals: (a) Nuclear
medicine physician; (b) Nuclear
cardiologist; (c) two radiation
oncologists; (d) diagnostic radiologist;
(e) therapy medical physicist; (f) nuclear
medicine physicist; (g) nuclear
pharmacist; (h) health care
administrator; (i) radiation safety officer;
(j) patients’ rights advocate; (k) Food
and Drug Administration representative;
and (l) Agreement State representative.
For additional information about
membership on the ACMUI, visit the
ACMUI Membership web page, https://
www.nrc.gov/about-nrc/regulatory/
advisory/acmui/membership.html.
The ACMUI Radiation Safety Officer
provides advice to NRC staff on health
physics issues associated with medical
applications of byproduct material. This
advice includes providing input on NRC
PO 00000
Frm 00130
Fmt 4703
Sfmt 4703
42905
proposed rules and guidance
documents; providing recommendations
on the training and experience of
radiation safety officers; identification
of medical events; evaluating nonroutine uses of byproduct material;
bringing key issues in the radiation
safety officer community to the
attention of NRC staff; evaluating the
security of byproduct material used in
medical and research facilities, and
other issues as they relate to radiation
safety and NRC medical-use policy. This
individual is appointed based on their
educational background, certification(s),
work experience, involvement and/or
leadership in professional society
activities, and other information
obtained in recommendation letters or
during the selection process. Nominees
should have the demonstrated ability to
establish effective work relationships
with peers and implement successful
approaches to problem solving and
conflict resolution.
The ACMUI advises the NRC on
policy and technical issues that arise in
the regulation of the medical use of
byproduct material. Responsibilities of
an ACMUI member include providing
comments on changes to the NRC
regulations and guidance; evaluating
certain non-routine uses of byproduct
material; providing technical assistance
in licensing, inspection, and
enforcement cases; and bringing key
issues to the attention of the NRC staff,
for appropriate action. Committee
members currently serve a four-year
term and may be considered for
reappointment to an additional term.
Nominees must be U.S. citizens and
be able to devote approximately 160
hours per year to ACMUI business.
Members are expected to attend semiannual meetings at NRC headquarters in
Rockville, Maryland and to participate
in teleconferences or virtual meetings,
as needed. Members who are not
Federal employees are compensated for
their service. In addition, members are
reimbursed for travel (including per
diem in lieu of subsistence) and are
reimbursed secretarial and
correspondence expenses. Full-time
Federal employees are reimbursed for
travel expenses only.
Security Background Check: The
selected nominee will undergo a
thorough security background check.
Security paperwork may take the
nominee several weeks to complete.
Nominees will also be required to
complete a financial disclosure
statement to avoid conflicts of interest.
Dated at Rockville, Maryland this 2nd day
of August 2021.
E:\FR\FM\05AUN1.SGM
05AUN1
42906
Federal Register / Vol. 86, No. 148 / Thursday, August 5, 2021 / Notices
For the U.S. Nuclear Regulatory
Commission.
Russell E. Chazell,
Federal Advisory Committee Management
Officer.
[FR Doc. 2021–16706 Filed 8–4–21; 8:45 am]
BILLING CODE 7590–01–P
NUCLEAR REGULATORY
COMMISSION
[NRC–2020–0235]
Information Collection: Financial
Protection Requirements and
Indemnity Agreements
Nuclear Regulatory
Commission.
ACTION: Notice of Submission to the
Office of Management and Budget;
Request for Comment.
AGENCY:
The U.S. Nuclear Regulatory
Commission (NRC) has recently
submitted a request for renewal of an
existing collection of information to the
Office of Management and Budget
(OMB) for review. The information
collection is entitled, ‘‘Financial
Protection Requirements and Indemnity
Agreements.’’
DATES: Submit comments by September
7, 2021. Comments received after this
date will be considered if it is practical
to do so, but the Commission is able to
ensure consideration only for comments
received on or before this date.
ADDRESSES: Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to https://www.reginfo.gov/
public/do/PRAMain. Find this
particular information collection by
selecting ‘‘Currently under Review—
Open for Public Comments’’ or by using
the search function.
FOR FURTHER INFORMATION CONTACT:
David Cullison, NRC Clearance Officer,
U.S. Nuclear Regulatory Commission,
Washington, DC 20555–0001; telephone:
301–415–2084; email:
Infocollects.Resource@nrc.gov.
SUPPLEMENTARY INFORMATION:
SUMMARY:
khammond on DSKJM1Z7X2PROD with NOTICES
I. Obtaining Information and
Submitting Comments
A. Obtaining Information
Please refer to Docket ID NRC–2020–
0235 when contacting the NRC about
the availability of information for this
action. You may obtain publicly
available information related to this
action by any of the following methods:
• Federal Rulemaking Website: Go to
https://www.regulations.gov/ and search
for Docket ID NRC–2020–0235.
VerDate Sep<11>2014
17:07 Aug 04, 2021
Jkt 253001
• NRC’s Agencywide Documents
Access and Management System
(ADAMS): You may obtain publicly
available documents online in the
ADAMS Public Documents collection at
https://www.nrc.gov/reading-rm/
adams.html. To begin the search, select
‘‘Begin Web-based ADAMS Search.’’ For
problems with ADAMS, please contact
the NRC’s Public Document Room (PDR)
reference staff at 1–800–397–4209, 301–
415–4737, or by email to pdr.resource@
nrc.gov. The supporting statement and
burden spreadsheet are available in
ADAMS under Accession Nos.
ML21134A185 and ML21013A488.
• NRC’s Clearance Officer: A copy of
the collection of information and related
instructions may be obtained without
charge by contacting the NRC’s
Clearance Officer, David Cullison,
Office of the Chief Information Officer,
U.S. Nuclear Regulatory Commission,
Washington, DC 20555–0001; telephone:
301–415–2084; email:
Infocollects.Resource@nrc.gov.
B. Submitting Comments
Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to https://www.reginfo.gov/
public/do/PRAMain. Find this
particular information collection by
selecting ‘‘Currently under Review—
Open for Public Comments’’ or by using
the search function.
The NRC cautions you not to include
identifying or contact information in
comment submissions that you do not
want to be publicly disclosed in your
comment submission. All comment
submissions are posted at https://
www.regulations.gov/ and entered into
ADAMS. Comment submissions are not
routinely edited to remove identifying
or contact information.
If you are requesting or aggregating
comments from other persons for
submission to the OMB, then you
should inform those persons not to
include identifying or contact
information that they do not want to be
publicly disclosed in their comment
submission. Your request should state
that comment submissions are not
routinely edited to remove such
information before making the comment
submissions available to the public or
entering the comment into ADAMS.
II. Background
Under the provisions of the
Paperwork Reduction Act of 1995 (44
U.S.C. chapter 35), the NRC recently
submitted a request for renewal of an
existing collection of information to
OMB for review entitled, ‘‘Financial
PO 00000
Frm 00131
Fmt 4703
Sfmt 4703
Protection Requirements and Indemnity
Agreements.’’ The NRC hereby informs
potential respondents that an agency
may not conduct or sponsor, and that a
person is not required to respond to, a
collection of information unless it
displays a currently valid OMB control
number.
The NRC published a Federal
Register notice with a 60-day comment
period on this information collection on
April 1, 2021, 86 FR 17216.
1. The Title of the Information
Collection: Part 140 of title 10 of the
Code of Federal Regulations (10 CFR),
‘‘Financial Protection Requirements and
Indemnity Agreements.
2. OMB Approval Number: 3150–
0039.
3. Type of Submission: Extension.
4. The Form Number, If Applicable:
Not applicable.
5. How Often the Collection Is
Required or Requested: Annually, and
on occasion, as needed for applicants
and licensees to meet their
responsibilities called for in Sections
170 and 193 of the Atomic Energy Act
of 1954.
6. Who Will Be Required or Asked To
Respond: Each applicant for or holder of
a license issued under 10 CFR parts 50
or 54, to operate a nuclear reactor, or the
applicant for or holder of a combined
license issued under 10 CFR parts 52 or
54, as well as licensees authorized to
possess and use plutonium in a
plutonium processing and fuel
fabrication plant. In addition, licensees
authorized to construct and operate a
uranium enrichment facility in
accordance with 10 CFR parts 40 and
70.
7. The Estimated Number of Annual
Responses: 208.
8. The Estimated Number of Annual
Respondents: 104.
9. The Estimated Number of Hours
Needed Annually To Comply With the
Information Collection Requirement or
Request: The total reporting and
recordkeeping burden is 753 (727 hours
reporting + 26 hours recordkeeping).
10. Abstract: 10 CFR part 140
specifies the information to be
submitted by licensees that enables the
NRC to assess (a) financial protection
required by licensees and for the
indemnification and limitation of
liability of certain licensees and other
persons pursuant to Section 170 of the
Atomic Energy Act of 1954, as amended,
and (b) the liability insurance required
opinion.
Dated: August 2, 2021.
E:\FR\FM\05AUN1.SGM
05AUN1
]]>Agencies
[Federal Register Volume 86, Number 148 (Thursday, August 5, 2021)]
[Notices]
[Pages 42905-42906]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-16706]
=======================================================================
-----------------------------------------------------------------------
NUCLEAR REGULATORY COMMISSION
Advisory Committee on the Medical Uses of Isotopes: Call for
Nominations
AGENCY: U.S. Nuclear Regulatory Commission.
ACTION: Call for nominations.
-----------------------------------------------------------------------
SUMMARY: The U.S. Nuclear Regulatory Commission (NRC) is soliciting
nominations for the position of Radiation Safety Officer on the
Advisory Committee on the Medical Uses of Isotopes (ACMUI). Nominees
should currently be functioning as a Radiation Safety Officer.
DATES: Nominations are due on or before October 4, 2021.
FOR FURTHER INFORMATION CONTACT: Ms. Kellee Jamerson, U.S. Nuclear
Regulatory Commission, Office of Nuclear Material Safety and
Safeguards; (301) 415-7408; [email protected].
SUPPLEMENTARY INFORMATION:
Nomination Process: Submit an electronic copy of resume or
curriculum vitae, along with a cover letter, to Ms. Kellee Jamerson,
[email protected]. The cover letter should describe the nominee's
current involvement as a Radiation Safety Officer and express the
nominee's interest in the position. Please ensure that the resume or
curriculum vitae includes the following information, if applicable:
Education; certification(s); professional association and committee
membership activities; duties and responsibilities in current and
previous clinical, research, and/or academic position(s).
ACMUI members possess the medical and technical skills needed to
address evolving issues. The current membership is comprised of the
following professionals: (a) Nuclear medicine physician; (b) Nuclear
cardiologist; (c) two radiation oncologists; (d) diagnostic
radiologist; (e) therapy medical physicist; (f) nuclear medicine
physicist; (g) nuclear pharmacist; (h) health care administrator; (i)
radiation safety officer; (j) patients' rights advocate; (k) Food and
Drug Administration representative; and (l) Agreement State
representative. For additional information about membership on the
ACMUI, visit the ACMUI Membership web page, https://www.nrc.gov/about-nrc/regulatory/advisory/acmui/membership.html.
The ACMUI Radiation Safety Officer provides advice to NRC staff on
health physics issues associated with medical applications of byproduct
material. This advice includes providing input on NRC proposed rules
and guidance documents; providing recommendations on the training and
experience of radiation safety officers; identification of medical
events; evaluating non-routine uses of byproduct material; bringing key
issues in the radiation safety officer community to the attention of
NRC staff; evaluating the security of byproduct material used in
medical and research facilities, and other issues as they relate to
radiation safety and NRC medical-use policy. This individual is
appointed based on their educational background, certification(s), work
experience, involvement and/or leadership in professional society
activities, and other information obtained in recommendation letters or
during the selection process. Nominees should have the demonstrated
ability to establish effective work relationships with peers and
implement successful approaches to problem solving and conflict
resolution.
The ACMUI advises the NRC on policy and technical issues that arise
in the regulation of the medical use of byproduct material.
Responsibilities of an ACMUI member include providing comments on
changes to the NRC regulations and guidance; evaluating certain non-
routine uses of byproduct material; providing technical assistance in
licensing, inspection, and enforcement cases; and bringing key issues
to the attention of the NRC staff, for appropriate action. Committee
members currently serve a four-year term and may be considered for
reappointment to an additional term.
Nominees must be U.S. citizens and be able to devote approximately
160 hours per year to ACMUI business. Members are expected to attend
semi-annual meetings at NRC headquarters in Rockville, Maryland and to
participate in teleconferences or virtual meetings, as needed. Members
who are not Federal employees are compensated for their service. In
addition, members are reimbursed for travel (including per diem in lieu
of subsistence) and are reimbursed secretarial and correspondence
expenses. Full-time Federal employees are reimbursed for travel
expenses only.
Security Background Check: The selected nominee will undergo a
thorough security background check. Security paperwork may take the
nominee several weeks to complete. Nominees will also be required to
complete a financial disclosure statement to avoid conflicts of
interest.
Dated at Rockville, Maryland this 2nd day of August 2021.
[[Page 42906]]
For the U.S. Nuclear Regulatory Commission.
Russell E. Chazell,
Federal Advisory Committee Management Officer.
[FR Doc. 2021-16706 Filed 8-4-21; 8:45 am]
BILLING CODE 7590-01-P
